OR7E66P

Across TCGA pan-cancer cohorts, OR7E66P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated OR7E66P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher OR7E66P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E66P expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

UCEC, DLBC, and BLCA are the cancer types where OR7E66P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.828	0.911	.004	66	view →
DLBC	OS	Tertile	All	0.539	1.000	.002	60	view →
BLCA	OS	Tertile	II,III,IV	0.601	0.378	.008	54	view →
PAAD	DFS	Tertile	All	0.339	0.510	.008	48	view →
STAD	DFS	Quartile	II,III,IV	0.436	0.581	.009	37	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
LAML	DFS	Tertile	All	0.158	0.623	<.001	36	view →
HNSC	DFS	Tertile	All	0.726	0.584	.016	27	view →
CHOL	DFS	Tertile	All	0.037	0.497	.004	18	view →
COAD	DFS	Tertile	IV	0.159	0.503	.006	18	view →
ACC	DFS	Tertile	All	0.218	0.765	<.001	18	view →
READ	DFS	Tertile	All	0.243	0.596	.024	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

OR7E66P–UCEC (DFS)

Open the UCEC breakdown →